Circulating DBP level and prognosis in operated lung cancer: an exploration of pathophysiology.

The European Respiratory Journal
Alice M TurnerBabu Naidu

Abstract

Vitamin D stimulates transcription of antiangiogenic and apoptotic factors that may suppress tumours, while vitamin D binding protein (DBP) may be a biomarker in murine lung cancer models. We sought to ascertain whether the vitamin D axis is altered in lung cancer or influences prognosis. 148 lung cancer patients, 68 other intrathoracic cancer patients and 33 noncancer controls were studied for up to 5 yrs. Circulating DBP and vitamin D levels were compared between groups and their effect on survival assessed by Cox regression analysis. Expression of DBP and vitamin D receptor (VDR) was examined in lung cancer cell lines and in normal and tumour lung tissue by Western blot and immunohistochemistry. Low serum DBP levels predicted lung cancer-specific death (p=0.04), and DBP was poorly expressed in lung cancer cells on Western blot and immunohistochemistry. Vitamin D did not predict cancer survival and VDR expression was variable in tumours. Preservation of serum DBP is a significant independent factor associated with better cancer outcome in operated lung cancer patients. Given the established role of DBP in macrophage activation and clearance of abnormal cells, further study on its involvement in lung cancer is merited.

Citations

Jul 26, 2012·Cancer Causes & Control : CCC·Ting-Yuan David Cheng, Marian L Neuhouser
Jul 31, 2013·Nutrients·Rachel E Foong, Graeme R Zosky
Dec 3, 2014·Lung Cancer : Journal of the International Association for the Study of Lung Cancer·Gabriella M AnicDemetrius Albanes
Sep 23, 2014·Translational Research : the Journal of Laboratory and Clinical Medicine·Robin T WilsonKaram El-Bayoumy
Apr 25, 2017·Experimental Biology and Medicine·Michal Reichert
Jun 9, 2018·The European Respiratory Journal·Om P Kurmi
Apr 14, 2017·The European Respiratory Journal·Heena KhiroyaAlice M Turner
Feb 25, 2018·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Yu-Fang HuangCheng-Yang Chou
Oct 28, 2020·International Journal of Molecular Sciences·Dominika RozmusAnna Cieślińska
Jun 6, 2021·The Science of the Total Environment·Wen LiuHelgi B Schiöth

❮ Previous
Next ❯

Related Concepts

Related Feeds

Angiogenesis Inhibitors to Treat Cancer

Cancer treatments including angiogenesis inhibitors prevent tumor cells from receiving nutrients and oxygen. Here is the latest research on angiogenesis inhibitors for the treatment of cancer.